Multi-environment gene interactions linked to the interplay between polysubstance dependence and suicidality.
- Authors
- Polimanti, Renato; Levey, Daniel F; Pathak, Gita A; Wendt, Frank R; Nunez, Yaira Z; Ursano, Robert J; Kessler, Ronald C; Kranzler, Henry R; Stein, Murray B; Gelernter, Joel
- Year
- 2021
- Journal
- Translational psychiatry
- PMID
- 33431810
- DOI
- 10.1038/s41398-020-01153-1
- PMCID
- PMC7801457
Substance dependence diagnoses (SDs) are important risk factors for suicidality. We investigated the associations of multiple SDs with different suicidality outcomes, testing how genetic background moderates these associations. The Yale-Penn cohort (Nβ=β15,557) was recruited to investigate the genetics of SDs. The Army STARRS (Study to Assess Risk and Resilience in Servicemembers) cohort (Nβ=β11,236) was recruited to evaluate mental health risk and resilience among Army personnel. We applied multivariate logistic regression to investigate the associations of SDs with suicidality and, in the Yale-Penn cohort, we used the structured linear mixed model (StructLMM) to study multivariate gene-environment interactions. In Yale-Penn, lifetime polysubstance dependence was strongly associated with lifetime suicidality: having five SDs showed an association with suicidality, from odds ratio (OR)β=β6.77 (95% confidence interval, CIβ=β5.74-7.99) for suicidal ideation (SI) to ORβ=β3.61 (95% CIβ=β2.7-4.86) for suicide attempt (SA). In Army STARRS, having multiple substance use disorders for alcohol and/or drugs was associated with increased suicidality ranging from ORβ=β2.88 (95% CIβ=β2.6-3.19) for SI to ORβ=β3.92 (95% CIβ=β3.19-4.81) for SA. In Yale-Penn, we identified multivariate gene-environment interactions (Bayes factors, BFβ>β0) of SI with respect to a gene cluster on chromosome 16 (LCAT, pβ=β1.82βΓβ10; TSNAXIP1, pβ=β2.13βΓβ10; CENPT, pβ=β2.32βΓβ10; PARD6A, pβ=β5.57βΓβ10) for opioid dependence (BFβ=β12.2), cocaine dependence (BFβ=β12.1), nicotine dependence (BFβ=β9.2), and polysubstance dependence (BFβ=β2.1). Comorbidity of multiple SDs is a significant associated with suicidality and heritability of suicidality is partially moderated by multivariate gene interactions.
Substance dependence (SD) and suicidality in Yale-Penn participants.Association of DSM-IV SD diagnoses (left panel) or polysubstance dependence severity (i.e., number of comorbid DSM-IV SD diagnosis; right panel) with suicidal ideation, persistent ideation, planning, and attempt.
LLM interpretation
This figure consists of two forest plots showing the association between substance dependence (SD) and various measures of suicidality (ideation, persistent ideation, planning, and attempt). The left panel displays odds ratios (OR) and 95% confidence intervals (CI) for specific DSM-IV SD diagnoses, while the right panel shows the association based on the number of comorbid SD diagnoses (N=1 to 5). In both panels, most ORs are above 1.0, with the strongest associations generally observed for alcohol dependence and higher numbers of comorbid SD diagnoses.
Gene-based Manhattan plots generated from the multivariate GEWIS of suicide ideation.Bottom panel: interactive effects where persistent genetic and additive environment effects are accounted for in the null model; Top panel: association effects accounting for the heterogeneous effect size due to the interactive effects). Red dashed line represents the significance threshold accounting for the gene-based Bonferroni multiple testing correction.
LLM interpretation
This figure consists of two gene-based Manhattan plots showing the association between genetic loci and suicide ideation across 22 chromosomes. The y-axis represents the $-\log_{10}$ P-value, and a red dashed line indicates the Bonferroni-corrected significance threshold. In both the top (association effects) and bottom (interactive effects) panels, several significant peaks are visible on chromosome 16, with specific genes labeled including *LCAT*, *TSNAXIP1*, *CENPT*, and *PARD6A*.
Regional Manhattan plot of the lead variant rs8052287.This was identified in the gene-based multivariate GEWIS of suicide ideation (Yale-Penn participants of European descent) Functional annotation derived from CADD (Combined Annotation Dependent Depletion) and RegulomeDB scores and 15-core chromatin state information across 13 brain tissues is included below. CADD scores > 20 corresponds to top-1% of pathogenicity across the human genome. RegulomeDB Score = 1 (f to a) corresponds to variants located within a transcription factor binding that shows eQTL activity.
LLM interpretation
This figure presents a regional Manhattan plot for the lead variant rs8052287 on Chromosome 16, with the y-axis showing $-\log_{10}$ P-values and points color-coded by linkage disequilibrium ($r^2$). Below the plot, a genomic map identifies mapped genes, categorized as non-protein coding (grey) or non-mapped protein coding (blue). The bottom panels provide functional annotations for the variants, including CADD scores, RegulomeDB scores, and a multi-colored heatmap representing chromatin states across 13 brain tissues.
| Name | Type |
|---|---|
| 23andMe | cohort |
| ACD local | gene |
| African American | cohort |
| African-Americans | cohort |
| age | phenotype |
| alcohol | phenotype |
| Alcohol and cocaine use disorder local | phenotype |
| Alcohol and marijuana use disorder local | phenotype |
| alcohol dependence | phenotype |
| Alcohol Use Disorder | phenotype |
| amphetamine | drug |
| Amphetamine use disorder | phenotype |
| anthropometric traits | phenotype |
| anxiety | phenotype |
| Army STARRS | cohort |
| Army STARRS participants local | cohort |
| Attempt local | phenotype |
| Been in serious accident believed to be life-threatening local | phenotype |
| brain tissue | anatomy |
| C16orf86 local | gene |
| CADD | drug |
| cannabis dependence | phenotype |
| Cannabis Dependence local | drug |
| cannabis use | phenotype |
| cannabis use disorder | phenotype |
| CARMIL2 local | gene |
| caudate nucleus | anatomy |
| CENPT local | gene |
| central nervous system | anatomy |
| cerebellar hemisphere | anatomy |
| cerebellum | anatomy |
| cigarettes | phenotype |
| cocaine | phenotype |
| cocaine dependence local | drug |
| cocaine use disorder | phenotype |
| CoD criterion counts local | phenotype |
| Combined Substance Use Disorder local | phenotype |
| controls | cohort |
| co-occurrence of multiple SD diagnoses local | phenotype |
| cortex | anatomy |
| cotinine | drug |
| depression | phenotype |
| DSMβIV mental disorders local | phenotype |
| DUS2 local | gene |
| European ancestry | cohort |
| European population | cohort |
| fatigue | phenotype |
| FHOD1 local | gene |
| frontal cortex BA9 local | anatomy |
| GTEx local | drug |
| GWAS Atlas local | drug |
| height | phenotype |
| hematological parameters local | phenotype |
| HGF local | gene |
| HSD11B2 | gene |
| hypothyroidism | phenotype |
| Ideation local | phenotype |
| illicit drug use | phenotype |
| Illumina Exome array local | drug |
| Illumina OmniExpress | drug |
| Illumina PsychChip array local | drug |
| KCTD19 local | gene |
| LCAT local | gene |
| lifeβthreatening traumatic events local | phenotype |
| loneliness | phenotype |
| long-term opioid users local | cohort |
| LRRC36 local | gene |
| MAGMA | drug |
| major depressive disorder | phenotype |
| male hair loss local | phenotype |
| male hair loss pattern local | phenotype |
| marijuana | phenotype |
| MD | phenotype |
| MD PRS local | variant |
| mean corpuscular hemoglobin local | phenotype |
| mood disorders | phenotype |
| mood swings | phenotype |
| National Survey of Drug Use and Health (NSDUH) cohort local | cohort |
| ND criterion counts local | phenotype |
| New Soldier Study local | cohort |
| nicotine | drug |
| nicotine dependence | phenotype |
| nucleus accumbens | anatomy |
| OD criterion counts local | phenotype |
| opioid | drug |
| opioid dependence local | drug |
| opioid dependence | phenotype |
| Painkiller local | drug |
| Painkiller use disorder local | phenotype |
| PARD6A local | gene |
| Persistent Ideation local | phenotype |
| persistent SI local | phenotype |
| Persistent suicidal ideation local | phenotype |
| Persistent Suicidal Ideation local | phenotype |
| PGC | cohort |
| PGC MD cohort local | cohort |
| planning | phenotype |
| polygenic risk score | cohort |
| polysubstance dependence | phenotype |
| Polysubstance dependence local | drug |
| Polysubstance Dependence Severity local | phenotype |
| Pre-Post Deployment Study local | cohort |
| Psychiatric Genomic Consortium local | cohort |
| RANBP10 local | gene |
| RegulomeDB | drug |
| rs62620177 local | variant |
| rs8052287 local | variant |
| SA | phenotype |
| SD diagnoses local | phenotype |
| SD-related traits local | phenotype |
| sedative dependence | phenotype |
| sedatives | drug |
| Self-reported racial/ethnic groups local | phenotype |
| sex | phenotype |
| SI outcome local | phenotype |
| SP | phenotype |
| StructLMM local | drug |
| Substance dependence (SD) local | phenotype |
| Substance Dependence (SDs) local | phenotype |
| substance use | phenotype |
| Substance use disorder combined local | phenotype |
| suicidality spectrum local | phenotype |
| suicide | phenotype |
| suicide risk | phenotype |
| thyroid autoimmunity local | phenotype |
| thyroid function local | phenotype |
| thyroid-stimulating hormone local | drug |
| thyroid storm local | phenotype |
| thyrotropin-releasing hormone local | drug |
| TSNAXIP1 local | gene |
| UK Biobank | cohort |
| Veterans Health Administration (VHA) cohort local | cohort |
| Yale-Penn | cohort |
| Yale-Penn African descent cohort local | cohort |
| Yale-Penn cohort | cohort |
| YaleβPenn cohort | cohort |
| Yale-Penn participants of European descent local | cohort |
| ZDHHC1 local | gene |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | 2022 | 36207451 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Prospective associations of alcohol and drug misuse with suicidal behaviors among US Army soldiers who have left active service. | Campbell-Sills L et al. | β | 2025 | β |
| The Roots of Problematic Polydrug Use in Emotional Problems and Suicide Behavior: A Cross-Sectional Study. | Martinez TE et al. | β | 2025 | β |
| Divorce, genetic risk, and suicidal thoughts and behaviors in a sample with recurrent major depressive disorder. | Edwards AC et al. | β | 2024 | β |
| Effects of sex and gender on the etiologies and presentation of select internalizing psychopathologies. | Singh K et al. | β | 2024 | β |
| The role of substance use disorders in the transition from suicide attempt to suicide death: a record linkage study of a Swedish cohort. | Edwards AC et al. | β | 2024 | β |
| Using the Strategy of Genome-Wide Association Studies to Identify Genetic Markers of Suicidal Behavior: A Narrative Review. | Rozanov V et al. | β | 2024 | β |
| Functional and molecular characterization of suicidality factors using phenotypic and genome-wide data. | Quintero Reis A et al. | β | 2023 | β |
| Genetic differences between suicide deaths and deaths of undetermined intent. | Edwards AC et al. | β | 2023 | β |
| How to save a life: From neurobiological underpinnings to psychopharmacotherapies in the prevention of suicide. | Gonda X et al. | β | 2023 | β |
| Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample. | Kember RL et al. | β | 2023 | β |
| Role of polygenic risk scores in the association between chronotype and health risk behaviors. | Zhang Y et al. | β | 2023 | β |
| Shared genetic and environmental etiology between substance use disorders and suicidal behavior. | Edwards AC et al. | β | 2023 | β |
| The shared genetic architecture of suicidal behaviour and psychiatric disorders: A genomic structural equation modelling study. | Kootbodien T et al. | β | 2023 | β |
| Genetics and epigenetics of self-injurious thoughts and behaviors: Systematic review of the suicide literature and methodological considerations. | Mirza S et al. | β | 2022 | β |
| Genome-Wide Interaction Study of Late-Onset Asthma With Seven Environmental Factors Using a Structured Linear Mixed Model in Europeans. | Baek EJ et al. | β | 2022 | β |
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | Gaddis N et al. | β | 2022 | β |
| Psychosocial moderators of polygenic risk for suicidal ideation: Results from a 7-year population-based, prospective cohort study of U.S. veterans. | Na PJ et al. | β | 2022 | β |
| Risk of non-fatal suicide attempt in individuals with substance use disorder: the roles of aggregate genetic liability and environmental exposures in a Swedish population-based cohort. | Lannoy S et al. | β | 2022 | β |
| Exploring the genetic overlap of suicide-related behaviors and substance use disorders. | Colbert SMC et al. | β | 2021 | β |
| Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective. | Wendt FR et al. | β | 2020 | β |